Vikram Karnani Insider Trading $HZNP Horizon Therapeutics Public Ltd Co
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Vikram Karnani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vikram Karnani. Vikram Karnani is EVP & President, International in Horizon Therapeutics Public Ltd Co ($HZNP) and EVP, Chief Commercial Officer in Horizon Pharma plc ($HZNP) and SVP, Rheumatology Bus. Unit in Horizon Pharma plc ($HZNP).
Vikram Karnani in Horizon Therapeutics Public Ltd Co
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Vikram Karnani: EVP & President, International, EVP, Chief Commercial Officer, SVP, Rheumatology Bus. Unit
Holdings: 111,429 shares
Current Value: $1,878,693
Latest Transaction: Jan 08 2021
$HZNP Market Capitalization: $2.68B
$HZNP Previous Close: $16.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Vikram Karnani in Horizon Therapeutics Public Ltd Co
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08 2021 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Sell | S | 75.00 | 30,031 | 2,252,325 | 111,429 | 141.5 K to 111.4 K (-21.23 %) |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Option Exercise | M | 0.00 | 12,094 | 0 | 24,190 | |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Option Exercise | M | 0.00 | 17,260 | 0 | 0 | |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Option Exercise | M | 0.00 | 17,983 | 0 | 17,983 | |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Option Exercise | A | 0.00 | 20,957 | 0 | 20,957 | |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Payment of Exercise | F | 73.28 | 49,906 | 3,657,112 | 141,460 | 191.4 K to 141.5 K (-26.08 %) |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Grant | A | 0.00 | 65,088 | 0 | 191,366 | 126.3 K to 191.4 K (+51.54 %) |
| Jan 06 2021 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Buy | M | 0.00 | 47,337 | 0 | 126,278 | 78.9 K to 126.3 K (+59.97 %) |
| Aug 05 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Option Exercise | M | 22.14 | 11,172 | 247,348 | 72,828 | |
| Aug 05 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Option Exercise | M | 9.23 | 25,600 | 236,288 | 0 | |
| Aug 05 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Buy | M | 22.14 | 11,172 | 247,348 | 78,941 | 67.8 K to 78.9 K (+16.49 %) |
| Aug 05 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP & President, In ... | Buy | M | 9.23 | 25,600 | 236,288 | 67,769 | 42.2 K to 67.8 K (+60.71 %) |
| Jun 02 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Sell | S | 50.23 | 2,369 | 118,995 | 42,169 | 44.5 K to 42.2 K (-5.32 %) |
| Apr 30 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Sell | S | 35.00 | 15,683 | 548,905 | 43,489 | 59.2 K to 43.5 K (-26.50 %) |
| Apr 30 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Sell | S | 35.01 | 30,063 | 1,052,506 | 59,172 | 89.2 K to 59.2 K (-33.69 %) |
| Feb 21 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 30,014 | 0 | 30,014 | |
| Feb 21 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 36.06 | 6,649 | 239,763 | 89,235 | 95.9 K to 89.2 K (-6.93 %) |
| Feb 21 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Grant | A | 0.00 | 15,007 | 0 | 95,884 | 80.9 K to 95.9 K (+18.56 %) |
| Jan 23 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 10,708 | 0 | 10,708 | |
| Jan 23 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 38.25 | 2,372 | 90,729 | 81,127 | 83.5 K to 81.1 K (-2.84 %) |
| Jan 23 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Grant | A | 0.00 | 5,353 | 0 | 83,499 | 78.1 K to 83.5 K (+6.85 %) |
| Jan 07 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 17,260 | 0 | 17,260 | |
| Jan 07 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 17,982 | 0 | 35,966 | |
| Jan 07 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 36,284 | 0 | 36,284 | |
| Jan 07 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Sell | S | 35.62 | 9,297 | 331,159 | 78,146 | 87.4 K to 78.1 K (-10.63 %) |
| Jan 07 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 36.10 | 24,225 | 874,523 | 87,443 | 111.7 K to 87.4 K (-21.69 %) |
| Jan 07 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Grant | A | 0.00 | 19,014 | 0 | 111,668 | 92.7 K to 111.7 K (+20.52 %) |
| Jan 07 2020 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 35,242 | 0 | 92,654 | 57.4 K to 92.7 K (+61.38 %) |
| Jul 03 2019 | HZNP | Horizon Therapeuti ... | Karnani Vikram | EVP, Chief Commerci ... | Sell | S | 25.02 | 13,111 | 327,980 | 57,412 | 70.5 K to 57.4 K (-18.59 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 9,500 | 0 | 0 | |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 68,154 | 72.4 K to 68.2 K (-5.82 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 26.84 | 4,209 | 112,970 | 68,154 | 72.4 K to 68.2 K (-5.82 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 9,500 | 0 | 72,363 | 62.9 K to 72.4 K (+15.11 %) |
| Mar 25 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 9,500 | 0 | 72,363 | 62.9 K to 72.4 K (+15.11 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 21.54 | 8,622 | 185,718 | 62,863 | 71.5 K to 62.9 K (-12.06 %) |
| Feb 22 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Grant | A | 0.00 | 19,014 | 0 | 71,485 | 52.5 K to 71.5 K (+36.24 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 17,259 | 0 | 34,520 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 53,948 | 0 | 53,948 | |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 52,471 | 60.4 K to 52.5 K (-13.17 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 20.39 | 7,962 | 162,345 | 52,471 | 60.4 K to 52.5 K (-13.17 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 17,259 | 0 | 60,433 | 43.2 K to 60.4 K (+39.98 %) |
| Jan 08 2019 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 17,259 | 0 | 60,433 | 43.2 K to 60.4 K (+39.98 %) |
| Aug 01 2018 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 5,675 | 0 | 0 | |
| Aug 01 2018 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 17.63 | 1,663 | 29,319 | 43,174 | 44.8 K to 43.2 K (-3.71 %) |
| Aug 01 2018 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 5,675 | 0 | 44,837 | 39.2 K to 44.8 K (+14.49 %) |
| May 07 2018 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 51,779 | 0 | 51,779 | |
| May 07 2018 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 51,779 | 0 | 51,779 | |
| Mar 27 2018 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 9,500 | 0 | 9,500 | |
| Mar 27 2018 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Payment of Exercise | F | 13.86 | 4,209 | 58,337 | 36,791 | 41 K to 36.8 K (-10.27 %) |
| Mar 27 2018 | HZNP | Horizon Pharma plc | Karnani Vikram | EVP, Chief Commerci ... | Buy | M | 0.00 | 9,500 | 0 | 41,000 | 31.5 K to 41 K (+30.16 %) |
| Jul 31 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Option Exercise | M | 0.00 | 5,675 | 0 | 5,675 | |
| Jul 31 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Payment of Exercise | F | 11.98 | 2,662 | 31,891 | 31,500 | 34.2 K to 31.5 K (-7.79 %) |
| Jul 31 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Buy | M | 0.00 | 5,675 | 0 | 34,162 | 28.5 K to 34.2 K (+19.92 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Option Exercise | M | 0.00 | 9,500 | 0 | 19,000 | |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Payment of Exercise | F | 14.56 | 2,955 | 43,025 | 27,059 | 30 K to 27.1 K (-9.85 %) |
| Mar 24 2017 | HZNP | Horizon Pharma plc | Karnani Vikram | SVP, Rheumatology B ... | Buy | M | 0.00 | 9,500 | 0 | 30,014 | 20.5 K to 30 K (+46.31 %) |
Page: 1